In the United States, Celltrion DiaTrust COVID-19 Ag Home Test, a rapid antigen self-diagnosis kit jointly developed by Celltrion and Humasys, is out of stock.
It is interpreted that this is because the demand for self-diagnostic kits has surged due to the rapid spread of Omicron mutations in the United States.
On the 7th, a Celltrion official said, “The Arthurst is running out of stock at Amazon, which has recently opened stores.
Celltrion recently placed this product in the American online shopping mall ‘Amazon’ and started selling it. Celltrion explained that it was initially pushing to enter the store in the form of an open market on Amazon, but in the process, it received direct contact from Amazon and signed a distribution and sales contract between the two companies.
A Celltrion official said, “We supply the quantity by signing a direct contract with Amazon.
According to Celltrion, this product is a COVID-19 self-test kit that received emergency use approval from the US Food and Drug Administration (FDA) in October last year. Celltrion USA is supplying it to the US Department of Defense and others.
Meanwhile, as of 9:49 am on the same day, the shares of Celltrion and Humasys both showed an upward trend. Celltrion is trading at 185,000 won, up 2.21% (4,000 won) from the previous day. Humasys is trading at 17,800 won, up 4.09% (700 won) from the previous day.
.
